Loading…
Based on limited metadata, this warning letter to Signature Formulations, LLC issued in July 2018 concerns an unspecified product type classified as "Other," though the specific nature of the violations cannot be determined without access to the full letter text. The issuing FDA office is not identified in the available metadata, which limits understanding of the precise regulatory scope and product category involved. To understand the specific compliance issues cited, the complete warning letter would need to be reviewed.